Mount Yale Investment Advisors, LLC - ADAPTIMMUNE THERAPEUTICS PLC ownership

ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 94 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q3 2018. The put-call ratio across all filers is 0.23 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of ADAPTIMMUNE THERAPEUTICS PLC
ValueSharesWeighting
Q3 2018$6,0008330.00%
Other shareholders
ADAPTIMMUNE THERAPEUTICS PLC shareholders Q3 2018
NameSharesValueWeighting ↓
Syncona Portfolio Ltd 1,377,294$5,165,0004.93%
Long Focus Capital Management, LLC 4,429,491$9,125,0001.17%
Endurant Capital Management LP 2,160,890$4,451,0001.17%
NEA Management Company, LLC 17,082,611$35,190,0001.02%
Matrix Capital Management Company, LP 38,974,185$80,287,0000.96%
Key Client Fiduciary Advisors, LLC 420,447$866,0000.68%
ACT CAPITAL MANAGEMENT, LLC 90,000$185,0000.20%
DAFNA Capital Management LLC 351,064$723,0000.19%
PFM Health Sciences, LP 2,374,674$4,892,0000.18%
Rock Springs Capital Management LP 2,297,194$4,732,0000.12%
View complete list of ADAPTIMMUNE THERAPEUTICS PLC shareholders